HEADER HYDROLASE 14-JAN-08 3BXR TITLE CRYSTAL STRUCTURES OF HIGHLY CONSTRAINED SUBSTRATE AND HYDROLYSIS TITLE 2 PRODUCTS BOUND TO HIV-1 PROTEASE. IMPLICATIONS FOR CATALYTIC TITLE 3 MECHANISM COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 491-589; COMPND 5 SYNONYM: RETROPEPSIN, PR; COMPND 6 EC: 3.4.23.16; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: CHEMICALLY SYNTHESIZED PROTEIN CORRESPONDING TO THE SOURCE 4 PROTEASE FROM THE HIV1 KEYWDS HIV PROTEASE, HIVPR, SUBSTRATE, PRODUCT, AIDS, ASPARTYL PROTEASE, KEYWDS 2 CAPSID MATURATION, CORE PROTEIN, CYTOPLASM, DNA INTEGRATION, DNA KEYWDS 3 RECOMBINATION, DNA-DIRECTED DNA POLYMERASE, ENDONUCLEASE, HYDROLASE, KEYWDS 4 LIPOPROTEIN, MAGNESIUM, MEMBRANE, METAL-BINDING, MULTIFUNCTIONAL KEYWDS 5 ENZYME, MYRISTATE, NUCLEASE, NUCLEOTIDYLTRANSFERASE, NUCLEUS, KEYWDS 6 PHOSPHOPROTEIN, RNA-BINDING, RNA-DIRECTED DNA POLYMERASE, KEYWDS 7 TRANSFERASE, VIRAL NUCLEOPROTEIN, VIRION, ZINC, ZINC-FINGER EXPDTA X-RAY DIFFRACTION AUTHOR J.D.TYNDALL,L.K.PATTENDEN,R.C.REID,S.H.HU,D.ALEWOOD,P.F.ALEWOOD, AUTHOR 2 T.WALSH,D.P.FAIRLIE,J.L.MARTIN REVDAT 6 15-NOV-23 3BXR 1 REMARK REVDAT 5 01-NOV-23 3BXR 1 REMARK REVDAT 4 10-NOV-21 3BXR 1 REMARK SEQADV LINK REVDAT 3 25-OCT-17 3BXR 1 REMARK REVDAT 2 24-FEB-09 3BXR 1 VERSN REVDAT 1 25-MAR-08 3BXR 0 JRNL AUTH J.D.TYNDALL,L.K.PATTENDEN,R.C.REID,S.H.HU,D.ALEWOOD, JRNL AUTH 2 P.F.ALEWOOD,T.WALSH,D.P.FAIRLIE,J.L.MARTIN JRNL TITL CRYSTAL STRUCTURES OF HIGHLY CONSTRAINED SUBSTRATE AND JRNL TITL 2 HYDROLYSIS PRODUCTS BOUND TO HIV-1 PROTEASE. IMPLICATIONS JRNL TITL 3 FOR THE CATALYTIC MECHANISM JRNL REF BIOCHEMISTRY V. 47 3736 2008 JRNL REFN ISSN 0006-2960 JRNL PMID 18311928 JRNL DOI 10.1021/BI7023157 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.L.MARTIN,J.BEGUN,A.SCHINDELER,W.A.WICKRAMASINGHE, REMARK 1 AUTH 2 D.ALEWOOD,P.F.ALEWOOD,D.A.BERGMAN,R.I.BRINKWORTH, REMARK 1 AUTH 3 G.ABBENANTE,D.R.MARCH,R.C.REID,D.P.FAIRLIE REMARK 1 TITL MOLECULAR RECOGNITION OF MACROCYCLIC PEPTIDOMIMETIC REMARK 1 TITL 2 INHIBITORS BY HIV-1 PROTEASE REMARK 1 REF BIOCHEMISTRY V. 38 7978 1999 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 10387041 REMARK 1 DOI 10.1021/BI990174X REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.0 REMARK 3 NUMBER OF REFLECTIONS : 22508 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.204 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2237 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.61 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2200 REMARK 3 BIN FREE R VALUE : 0.2600 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 35 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1499 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 69 REMARK 3 SOLVENT ATOMS : 207 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.19 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.96900 REMARK 3 B22 (A**2) : -0.10800 REMARK 3 B33 (A**2) : -0.86100 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.17 REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.446 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.014 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.453 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.298 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 88.06 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER.PARAM REMARK 3 PARAMETER FILE 3 : SO4_DUND_CH.PARAM REMARK 3 PARAMETER FILE 4 : SUBS_DUND.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3BXR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 17-JAN-08. REMARK 100 THE DEPOSITION ID IS D_1000046088. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-APR-98 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : YALE MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22699 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.7 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : 0.03400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 22.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.66 REMARK 200 COMPLETENESS FOR SHELL (%) : 64.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.09300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: PDB ENTRY 1CPI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.81 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: ACETATE, (NH4)2SO4, PH5.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K, VAPOR DIFFUSION, REMARK 280 HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.46500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 30.78500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.02500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 30.78500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.46500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.02500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4630 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9340 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -67.7 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 41 CG CD CE NZ REMARK 470 LYS A 43 CG CD CE NZ REMARK 470 LYS B 141 CG CD CE NZ REMARK 470 LYS B 143 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU B 135 121.11 -35.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 604 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DRR B 201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1B6P RELATED DB: PDB DBREF 3BXR A 1 99 UNP P03369 POL_HV1A2 491 589 DBREF 3BXR B 101 199 UNP P03369 POL_HV1A2 491 589 SEQADV 3BXR LYS A 7 UNP P03369 GLN 497 ENGINEERED MUTATION SEQADV 3BXR ASN A 25 UNP P03369 ASP 515 ENGINEERED MUTATION SEQADV 3BXR ILE A 33 UNP P03369 LEU 523 ENGINEERED MUTATION SEQADV 3BXR ABA A 67 UNP P03369 CYS 557 ENGINEERED MUTATION SEQADV 3BXR ABA A 95 UNP P03369 CYS 585 ENGINEERED MUTATION SEQADV 3BXR LYS B 107 UNP P03369 GLN 497 ENGINEERED MUTATION SEQADV 3BXR ASN B 125 UNP P03369 ASP 515 ENGINEERED MUTATION SEQADV 3BXR ILE B 133 UNP P03369 LEU 523 ENGINEERED MUTATION SEQADV 3BXR ABA B 167 UNP P03369 CYS 557 ENGINEERED MUTATION SEQADV 3BXR ABA B 195 UNP P03369 CYS 585 ENGINEERED MUTATION SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 A 99 ARG ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASN THR SEQRES 3 A 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET ASN LEU PRO SEQRES 4 A 99 GLY LYS TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 A 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO VAL GLU SEQRES 6 A 99 ILE ABA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 A 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 A 99 GLN ILE GLY ABA THR LEU ASN PHE SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 B 99 ARG ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASN THR SEQRES 3 B 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET ASN LEU PRO SEQRES 4 B 99 GLY LYS TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 B 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO VAL GLU SEQRES 6 B 99 ILE ABA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 B 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 B 99 GLN ILE GLY ABA THR LEU ASN PHE MODRES 3BXR ABA A 67 ALA ALPHA-AMINOBUTYRIC ACID MODRES 3BXR ABA A 95 ALA ALPHA-AMINOBUTYRIC ACID MODRES 3BXR ABA B 167 ALA ALPHA-AMINOBUTYRIC ACID MODRES 3BXR ABA B 195 ALA ALPHA-AMINOBUTYRIC ACID HET ABA A 67 6 HET ABA A 95 6 HET ABA B 167 6 HET ABA B 195 6 HET SO4 A 602 5 HET SO4 A 603 5 HET SO4 A 604 5 HET SO4 B 601 5 HET DRR B 201 49 HETNAM ABA ALPHA-AMINOBUTYRIC ACID HETNAM SO4 SULFATE ION HETNAM DRR (9S,12S)-9-(1-METHYLETHYL)-N-[(8S,11S)-8-[(1S)-1- HETNAM 2 DRR METHYLPROPYL]-7,10-DIOXO-2-OXA-6,9- HETNAM 3 DRR DIAZABICYCLO[11.2.2]HEPTADECA-1(15),13,16-TRIEN-11- HETNAM 4 DRR YL]-7,10-DIOXO-2-OXA-8,11- HETNAM 5 DRR DIAZABICYCLO[12.2.2]OCTADECA-1(16),14,17-TRIENE-12- HETNAM 6 DRR CARBOXAMIDE FORMUL 1 ABA 4(C4 H9 N O2) FORMUL 3 SO4 4(O4 S 2-) FORMUL 7 DRR C37 H51 N5 O7 FORMUL 8 HOH *207(H2 O) HELIX 1 1 GLY A 86 THR A 91 1 6 HELIX 2 2 GLY B 186 THR B 191 1 6 HELIX 3 3 GLN B 192 GLY B 194 5 3 SHEET 1 A 4 GLN A 2 ILE A 3 0 SHEET 2 A 4 THR B 196 ASN B 198 -1 O LEU B 197 N ILE A 3 SHEET 3 A 4 THR A 96 ASN A 98 -1 N ASN A 98 O THR B 196 SHEET 4 A 4 GLN B 102 ILE B 103 -1 O ILE B 103 N LEU A 97 SHEET 1 B 8 LYS A 43 GLY A 49 0 SHEET 2 B 8 GLY A 52 ILE A 66 -1 O GLN A 58 N LYS A 43 SHEET 3 B 8 HIS A 69 VAL A 77 -1 O HIS A 69 N ILE A 66 SHEET 4 B 8 VAL A 32 ILE A 33 1 N ILE A 33 O LEU A 76 SHEET 5 B 8 ILE A 84 ILE A 85 -1 O ILE A 84 N VAL A 32 SHEET 6 B 8 GLN A 18 LEU A 24 1 N LEU A 23 O ILE A 85 SHEET 7 B 8 LEU A 10 ILE A 15 -1 N ILE A 13 O LYS A 20 SHEET 8 B 8 GLY A 52 ILE A 66 -1 O GLU A 65 N ARG A 14 SHEET 1 C 8 LYS B 143 GLY B 149 0 SHEET 2 C 8 GLY B 152 ILE B 166 -1 O GLY B 152 N GLY B 149 SHEET 3 C 8 HIS B 169 GLY B 178 -1 O HIS B 169 N ILE B 166 SHEET 4 C 8 VAL B 132 GLU B 134 1 N ILE B 133 O LEU B 176 SHEET 5 C 8 ASN B 183 ILE B 185 -1 O ILE B 184 N VAL B 132 SHEET 6 C 8 GLN B 118 LEU B 124 1 N LEU B 123 O ASN B 183 SHEET 7 C 8 LEU B 110 ILE B 115 -1 N ILE B 113 O LYS B 120 SHEET 8 C 8 GLY B 152 ILE B 166 -1 O GLU B 165 N ARG B 114 LINK C ILE A 66 N ABA A 67 1555 1555 1.33 LINK C ABA A 67 N GLY A 68 1555 1555 1.33 LINK C GLY A 94 N ABA A 95 1555 1555 1.33 LINK C ABA A 95 N THR A 96 1555 1555 1.33 LINK C ILE B 166 N ABA B 167 1555 1555 1.33 LINK C ABA B 167 N GLY B 168 1555 1555 1.33 LINK C GLY B 194 N ABA B 195 1555 1555 1.33 LINK C ABA B 195 N THR B 196 1555 1555 1.33 SITE 1 AC1 6 GLY A 68 LYS A 70 HOH A 431 PRO B 101 SITE 2 AC1 6 LYS B 155 HOH B 479 SITE 1 AC2 5 PRO A 1 ARG A 57 HIS A 69 HOH A 386 SITE 2 AC2 5 HOH B 380 SITE 1 AC3 11 ARG A 14 GLY A 17 HOH A 378 HOH A 463 SITE 2 AC3 11 ARG B 114 ILE B 115 GLY B 116 GLY B 117 SITE 3 AC3 11 HOH B 319 HOH B 430 HOH B 478 SITE 1 AC4 5 MET A 36 ASN A 37 HOH A 358 PRO B 139 SITE 2 AC4 5 GLY B 140 SITE 1 AC5 25 ARG A 8 LEU A 23 GLY A 27 ALA A 28 SITE 2 AC5 25 ASP A 29 ILE A 47 GLY A 48 GLY A 49 SITE 3 AC5 25 ILE A 50 PRO A 81 ILE A 84 HOH A 302 SITE 4 AC5 25 ARG B 108 LEU B 123 ASN B 125 GLY B 127 SITE 5 AC5 25 ALA B 128 ASP B 129 GLY B 148 GLY B 149 SITE 6 AC5 25 ILE B 150 PRO B 181 ILE B 184 HOH B 301 SITE 7 AC5 25 HOH B 303 CRYST1 50.930 58.050 61.570 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019635 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017227 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016242 0.00000